ArticleThrombosis research2019

Enhanced potency of prasugrel on protease-activated receptors following bivalirudin treatment for PCI as compared to clopidogrel.

Carey Kimmelstiel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.